Heart failure & cardiomyopathiesResearch article
The Global, Regional, and National Burden of Myocarditis in 204 Countries and Territories, 1990–2021: Results From the Global Burden of Disease Study 2021
- Analysis of the Global Burden of Disease Study 2021
- global, regional and national analyses
- sub-analyses by age group, sex and SDI
Authors' conclusion
Although the ASRs of incidence, deaths, and DALYs significantly decreased from 1990 to 2021, the global number of incidences, deaths, and DALYs increased substantially. Certain populations, including males, children, the elderly, and regions with advanced sociodemographic levels, experienced a heavier burden of myocarditis.
Study context
- Population
- General population, global, 1990–2021
- Outcome
- Burden of myocarditis: incidence, deaths and DALYs with age-standardized rates (ASRs) per 100 000 population
- Follow-up
- 1990–2021
Main finding
As reported in the abstract
Global burden of myocarditis · 2021
- Incident cases, 2021
- 1.3 million (95% UI 1.1 to 1.6)
- Deaths, 2021
- 31.7 thousand (95% UI 25.5 to 37.1)
- DALY cases, 2021
- 96.3 thousand (95% UI 79.6 to 114.8)
- Percentage change in ASR of incidence, 1990–2021
- −3.9% (95% UI −4.7% to −2.9%)
- Percentage change in ASR of death, 1990–2021
- −28.2% (95% UI −42.2% to −12.5%)
- Percentage change in ASR of DALYs, 1990–2021
- −37.8% (95% UI −50.5% to −24.3%)
Further findings
Burden by sex, age and SDI
- Global burden higher in males, children and the elderly
- High SDI regions had the highest ASR of incidence
- High-middle SDI regions had the highest age-standardized rates (ASRs) of deaths and DALYs
Original publication
The Global, Regional, and National Burden of Myocarditis in 204 Countries and Territories, 1990–2021: Results From the Global Burden of Disease Study 2021. Eur J Heart Fail. Published 22 October 2024. doi:10.1002/ejhf.3483
Summarised from the published abstract; every number is checked against it